Johnson and Johnson has opened an office in the Stevenage Bioscience Catalyst in order to boost its open innovation efforts, reports pmlive.com.
The office is intended to link into J&J’s wider UK innovation focussed at the London Innovation Centre and will link with scientists and help to quicken early stage drug developments. The London site will have direct links with the Stevenage office, with scientists based in London travelling to Stevenage to converse and integrate with the businesses that have residencies at the Stevenage Bioscience Catalyst site.
The goal for J&J is to place “four regional innovation centres in life science hotspots such as London” according to Dr Kurt Hertogs, the incubator strategy leader at the London site. The intention is to support the biotech industry and advance promising healthcare solutions, which can be done through “collaboration within the unique incubator environment of Stevenage Bioscience Catalyst.” Dr Martino Picardo, the CEO of the Stevenage Bioscience Catalyst, believes J&J to be a “great partner” for the site.